← Leaderboards
Donald Small
Johns Hopkins University
$15,602,119
Attributed
$15,602,119
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2005–20$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$15,602,119 · 4
By mechanism
T32$6,742,288 · 1
R01$4,965,909 · 1
P01$2,537,051 · 1
U01$1,356,871 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Richard J Jones$17,555,212
- Mark J Levis$4,468,842
- Jason Eli Farrar$2,896,875
- Richard F. Ambinder$9,273,650
- George J Dover$7,479,087
Others in their field
Top investigators on “Leukemia”
- Richard K. Wilson · Washington University$209,620,938
- David Heimbrook · Leidos Biomedical Research, Inc.$168,419,678
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,967,203
- Peter C Adamson · National Childhood Cancer Foundation$143,910,899
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- Richard L Schilsky · University Of Chicago$129,102,207
Research focus
LeukemiaResearch TrainingMutantChemotherapyMutationCellsTyrosine Kinase InhibitorRelapseSignal TransductionMutateLeukemogenesisHematopoieticResponseKnock-In MouseGenesProtein Tyrosine KinaseStagingOutcome ForecastLeukemia, Myelocytic, AcuteTissue /Cell CultureDrug Discovery /IsolationPromotor (Genetics)Receptor Protein-Tyrosine KinasesGenetic
Grant awards (48)
Lab Research Training in Pediatric Oncology-Hematology$566,339
T32 · FY2020 · CA · contact PI
Lab Research Training in Pediatric Oncology-Hematology$600,046
T32 · FY2019 · CA · contact PI
Lab Research Training in Pediatric Oncology-Hematology$566,757
T32 · FY2018 · CA · contact PI
FLT3 Tyrosine Kinase Inhibitors as Therapy for Leukemia$291,600
R01 · FY2018 · CA · contact PI
Lab Research Training in Pediatric Oncology-Hematology$583,961
T32 · FY2017 · CA · contact PI
FLT3 Tyrosine Kinase Inhibitors as Therapy for Leukemia$291,600
R01 · FY2017 · CA · contact PI
Lab Research Training in Pediatric Oncology-Hematology$579,554
T32 · FY2016 · CA · contact PI
FLT3 Tyrosine Kinase Inhibitors as Therapy for Leukemia$291,600
R01 · FY2016 · CA · contact PI
Lab Research Training in Pediatric Oncology-Hematology$460,041
T32 · FY2015 · CA · contact PI
FLT3 Tyrosine Kinase Inhibitors as Therapy for Leukemia$291,600
R01 · FY2015 · CA · contact PI
Lab Research Training in Pediatric Oncology-Hematology$482,851
T32 · FY2014 · CA · contact PI
FLT3 Tyrosine Kinase Inhibitors as Therapy for Leukemia$291,600
R01 · FY2014 · CA · contact PI
Lab Research Training in Pediatric Oncology-Hematology$439,436
T32 · FY2013 · CA · contact PI
Lab Research Training in Pediatric Oncology-Hematology$58,417
T32 · FY2013 · CA · contact PI
Lab Research Training in Pediatric Oncology-Hematology$531,010
T32 · FY2012 · CA · contact PI
Flt3: Role in Leukemia Stem Cells$303,889
P01 · FY2012 · CA · contact PI
FLT3 Tyrosine Kinase Inhibitors as Therapy for Leukemia$284,804
R01 · FY2012 · CA · contact PI
Lab Research Training in Pediatric Oncology-Hematology$577,520
T32 · FY2011 · CA · contact PI
Flt3: Role in Leukemia Stem Cells$302,992
P01 · FY2011 · CA · contact PI
FLT3 Tyrosine Kinase Inhibitors as Therapy for Leukemia$284,804
R01 · FY2011 · CA · contact PI
Lab Research Training in Pediatric Oncology-Hematology$60,193
T32 · FY2011 · CA · contact PI
Lab Research Training in Pediatric Oncology-Hematology$538,114
T32 · FY2010 · CA · contact PI
Flt3: Role in Leukemia Stem Cells$341,104
P01 · FY2010 · CA · contact PI
FLT3 Tyrosine Kinase Inhibitors as Therapy for Leukemia$293,612
R01 · FY2010 · CA · contact PI
Lab Research Training in Pediatric Oncology-Hematology$59,195
T32 · FY2010 · CA · contact PI
Lab Research Training in Pediatric Oncology-Hematology$581,927
T32 · FY2009 · CA · contact PI
Flt3: Role in Leukemia Stem Cells$334,412
P01 · FY2009 · CA · contact PI
FLT3 Tyrosine Kinase Inhibitors as Therapy for Leukemia$293,612
R01 · FY2009 · CA · contact PI
Lab Research Training in Pediatric Oncology-Hematology$56,927
T32 · FY2009 · CA · contact PI
Flt3: Role in Leukemia Stem Cells$324,674
P01 · FY2008 · CA · contact PI
FLT3 Tyrosine Kinase Inhibitors as Therapy for Leukemia$293,612
R01 · FY2008 · CA · contact PI
FLT3 Tyrosine Kinase Inhibitors As Therapy for Leukemia$284,191
R01 · FY2006 · CA · contact PI
FLT3 Tyrosine Kinase Inhibitors As Therapy for Leukemia$166,718
R01 · FY2006 · CA · contact PI
FLT3 Tyrosine Kinase Inhibitors As Therapy for Leukemia$291,030
R01 · FY2005 · CA
FLT3 Tyrosine Kinase Inhibitors As Therapy for Leukemia$162,619
R01 · FY2005 · CA
FLT3 as a Target for Drug Discovery to Treat Leukemia$353,997
U01 · FY2004 · CA
FLT3 Tyrosine Kinase Inhibitors As Therapy for Leukemia$291,030
R01 · FY2004 · CA
FLT3 Tyrosine Kinase Inhibitors As Therapy for Leukemia$159,051
R01 · FY2004 · CA
FLT3 as a Target for Drug Discovery to Treat Leukemia$343,685
U01 · FY2003 · CA
FLT3 Tyrosine Kinase Inhibitors As Therapy for Leukemia$291,030
R01 · FY2003 · CA
FLT3 Tyrosine Kinase Inhibitors As Therapy for Leukemia$120,766
R01 · FY2003 · CA
FLT3 as a Target for Drug Discovery to Treat Leukemia$333,674
U01 · FY2002 · CA
FLT3 Tyrosine Kinase Inhibitors As Therapy for Leukemia$291,030
R01 · FY2002 · CA
FLT3: Role and regulation in HSC$228,564
P01 · FY2002 · CA
FLT3/STK1--REGULATION AND ROLE IN LEUKEMIA$228,564
P01 · FY2002 · CA
FLT3 as a Target for Drug Discovery to Treat Leukemia$325,515
U01 · FY2001 · CA
FLT3/STK1--REGULATION AND ROLE IN LEUKEMIA$228,564
P01 · FY2001 · CA
FLT3/STK1--REGULATION AND ROLE IN LEUKEMIA$244,288
P01 · FY2000 · CA